Antares Pharma, Inc. (NASDAQ: ATRS) today announced positive results from an open-label, randomized, crossover study comparing the systemic availability of MTX Medi-Jet to oral methotrexate (MTX) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback